Min Qiu

In situ cancer vaccination using lipidoid nanoparticles

Jianzhu Chen, Qiaobing Xu, Yamin Li, 2021, Science Advances.

Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis

Qiaobing Xu, E. Henske, Yan Tang, 2022, Proceedings of the National Academy of Sciences.

Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3

Mary E. Haas, Feng Zhang, Qiaobing Xu, 2021, Proceedings of the National Academy of Sciences.

Imidazole-based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes.

Qiaobing Xu, Yamin Li, Z. Glass, 2020, Angewandte Chemie.

The effects of protein corona on in vivo fate of nanocarriers.

Qiaobing Xu, Chao Teng, Marwa A. Sallam, 2022, Advanced drug delivery reviews.

Enhanced protein degradation by intracellular delivery of pre-fused PROTACs using lipid-like nanoparticles.

Qiaobing Xu, Z. Glass, Liu Yang, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response

Qiaobing Xu, Yamin Li, Donghui Song, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Non-viral nanoparticles for CRISPR-based genome editing: is it just a simple adaption of what have been developed for nucleic acid delivery?

Min Qiu, Zachary Glass, Qiaobing Xu, 2019, Biomacromolecules.

Imidazole‐Based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes

Qiaobing Xu, Yamin Li, Z. Glass, 2020, Angewandte Chemie.

Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.

Qiaobing Xu, Yamin Li, Min Qiu, 2021, Accounts of chemical research.